Asunra 400mg Tablet DT
Prescription Required
Product introduction
Asunra 400mg Tablet DT is a medicine used in the treatment of chronic iron overload caused by frequent blood transfusion. It helps remove the excess iron from the body and reduce the risk of it causing organ damage.
Repeated blood transfusions in some patients can cause a build-up of excess iron. Asunra 400mg Tablet DT is used to remove the excess iron from the body
Repeated blood transfusions in some patients can cause a build-up of excess iron. Asunra 400mg Tablet DT is used to remove the excess iron from the body
Uses of Asunra Tablet DT
Benefits of Asunra Tablet DT
In Treatment of Iron overload
Iron overload, as the name suggests, means excess of iron in the human body. Too much iron can cause organ damage, which can lead to conditions such as cancer, irregular heartbeat and cirrhosis of the liver. Symptoms are related to conditions that arise from iron overload such as high blood sugar levels (diabetes), darkening of the skin, abnormal heart rhythm or arthritis. By using Asunra 400mg Tablet DT, this excess of iron can be decreased to safe levels by removing it from the body through stools. This helps to reduce the risk of organ damage and prevents further complications. Take Asunra 400mg Tablet DT as prescribed by the doctor to get the maximum benefit.
Side effects of Asunra Tablet DT
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Asunra
- Nausea
- Headache
- Vomiting
- Rash
- Abdominal pain
- Constipation
- Itching
- Increased liver enzymes
- Abdominal distension
- Diarrhea
How to use Asunra Tablet DT
Take this medicine in the dose and duration as advised by your doctor. Dissolve it in a glass of water before taking it. Asunra 400mg Tablet DT is to be taken empty stomach.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Asunra 400mg Tablet DT. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Asunra 400mg Tablet DT may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Asunra 400mg Tablet DT is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
UNSAFE
Asunra 400mg Tablet DT may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
UNSAFE
Asunra 400mg Tablet DT is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor.
Liver
CAUTION
Asunra 400mg Tablet DT should be used with caution in patients with liver disease. Dose adjustment of Asunra 400mg Tablet DT may be needed. Please consult your doctor.
Limited information is available on the use of Asunra 400mg Tablet DT in these patients.
Limited information is available on the use of Asunra 400mg Tablet DT in these patients.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Asunra 400mg Tablet DT is used to reduce excess iron from the body.
- Inform your doctor if you also have upper stomach pain, clay-colored stools, or jaundice (yellowing of your skin or the whites of your eyes).
- Take an adequate amount of water while taking Asunra 400mg Tablet DT.
- Asunra 400mg Tablet DT may cause dizziness. It is advisable not to drive or operate any machinery until you feel normal again.
- If you are taking any antacid, take them 2 hours before or after Asunra 400mg Tablet DT.
- Inform your doctor if you have any liver or kidney disease.
- Inform your doctor if you are pregnant or breastfeeding.
Fact Box
Chemical Class
Triazole & benzoate derivative
Habit Forming
No
Therapeutic Class
BLOOD RELATED
Action Class
Iron chelating agents
Patient concerns
User feedback
Patients taking Asunra 400mg Tablet DT
Once A Day
88%
Twice A Day
7%
Thrice A Day
5%
What are you using Asunra Tablet DT for?
Transfusion d*
71%
Iron overload
29%
*Transfusion dependent thalassemia
How much was the improvement?
Average
52%
Excellent
29%
Poor
19%
What were the side-effects while using Asunra 400mg Tablet DT?
Nausea
40%
Vomiting
40%
No Side Effec*
20%
*No Side Effect
How do you take Asunra Tablet DT?
Empty stomach
100%
Please rate Asunra 400mg Tablet DT on price
Expensive
50%
Not Expensive
33%
Average
17%
FAQs
What is Asunra 400mg Tablet DT used for?
Asunra 400mg Tablet DT is used for removing excess iron from the body due to repeated blood transfusions in patients with beta thalassemia major (a blood disorder)
How does Asunra 400mg Tablet DT work?
Asunra 400mg Tablet DT works by binding to excess iron in the blood and removing it from the body through stool.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Byrns MC, Penning TM. Environmental Toxicology: Carcinogens and Heavy Metals. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1875-76.
- Kosnett MJ. Heavy Metal Intoxication & Chelators. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 1010.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 365.
- Deferasirox. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 2006 [revised 23 Jul. 2018]. [Accessed 6 Apr. 2019] (online) Available from:
- Medscaape. Deferasirox. [Accessed 6 Apr. 2019] (online) Available from:
- Deferasirox. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 2006 [revised 23 Jul. 2018]. [Accessed 25 Jan. 2019] (online) Available from:
- Drugs.com. Deferasirox Pregnancy and Breastfeeding Warnings. [Accessed 6 Apr. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 6 Apr. 2019] (online) Available from:
Marketer details
Name: Novartis India Ltd
Address: Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India
Country of origin: Switzerland
Lab tests offered by us
Related/Popular tests
444 people viewed this recentlyMRP
₹827
Inclusive of all taxes
6.0 tablet dt in 1 strip
SOLD OUT